Phospho-MEF2C (Ser222) Antibody - #AF3617
Product: | Phospho-MEF2C (Ser222) Antibody |
Catalog: | AF3617 |
Description: | Rabbit polyclonal antibody to Phospho-MEF2C (Ser222) |
Application: | IHC |
Reactivity: | Human, Mouse, Rat |
Mol.Wt.: | 51kD(Calculated). |
Uniprot: | Q06413 |
RRID: | AB_2846931 |
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# AF3617, RRID:AB_2846931.
Fold/Unfold
C5DELq14.3; DEL5q14.3; MADS box transcription enhancer factor 2 polypeptide C (myocyte enhancer factor 2C); MADS box transcription enhancer factor 2, polypeptide C; MEF2C; MEF2C_HUMAN; Myocyte enhancer factor 2C; Myocyte specific enhancer factor 2C; Myocyte-specific enhancer factor 2C; OTTHUMP00000222409; Similar to MADS box transcription enhancer factor 2 polypeptide C;
Immunogens
A synthesized peptide derived from human MEF2C around the phosphorylation site of Ser222.
- Q06413 MEF2C_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MGRKKIQITRIMDERNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNSTNKLFQYASTDMDKVLLKYTEYNEPHESRTNSDIVETLRKKGLNGCDSPDPDADDSVGHSPESEDKYRKINEDIDLMISRQRLCAVPPPNFEMPVSIPVSSHNSLVYSNPVSSLGNPNLLPLAHPSLQRNSMSPGVTHRPPSAGNTGGLMGGDLTSGAGTSAGNGYGNPRNSPGLLVSPGNLNKNMQAKSPPPMNLGMNNRKPDLRVLIPPGSKNTMPSVSEDVDLLLNQRINNSQSAQSLATPVVSVATPTLPGQGMGGYPSAISTTYGTEYSLSSADLSSLSGFNTASALHLGSVTGWQQQHLHNMPPSALSQLGACTSTHLSQSSNLSLPSTQSLNIKSEPVSPPRDRTTTPSRYPQHTRHEAGRSPVDSLSSCSSSYDGSDREDHRNEFHSPIGLTRPSPDERESPSVKRMRLSEGWAT
PTMs - Q06413 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
T20 | Phosphorylation | Uniprot | |
K23 | Ubiquitination | Uniprot | |
S59 | Phosphorylation | Uniprot | |
K64 | Ubiquitination | Uniprot | |
K68 | Ubiquitination | Uniprot | |
T80 | Phosphorylation | Q9H1R3 (MYLK2) | Uniprot |
S82 | Phosphorylation | Uniprot | |
T87 | Phosphorylation | Uniprot | |
S98 | Phosphorylation | Uniprot | |
S106 | Phosphorylation | Uniprot | |
S110 | Phosphorylation | Uniprot | |
K116 | Acetylation | Uniprot | |
K119 | Acetylation | Uniprot | |
S181 | Phosphorylation | Uniprot | |
S183 | Phosphorylation | Uniprot | |
S192 | Phosphorylation | P51812 (RPS6KA3) | Uniprot |
S222 | Phosphorylation | Uniprot | |
S228 | Phosphorylation | Uniprot | |
K234 | Acetylation | Uniprot | |
K239 | Acetylation | Uniprot | |
S240 | Phosphorylation | Uniprot | |
K252 | Acetylation | Uniprot | |
K264 | Acetylation | Uniprot | |
T293 | Phosphorylation | Q16539 (MAPK14) | Uniprot |
T300 | Phosphorylation | Q16539 (MAPK14) | Uniprot |
S387 | Phosphorylation | Q13164 (MAPK7) , Q16539 (MAPK14) | Uniprot |
T387 | Phosphorylation | Uniprot | |
K391 | Sumoylation | Uniprot | |
S396 | Phosphorylation | P06493 (CDK1) | Uniprot |
S419 | Phosphorylation | Uniprot | |
S445 | Phosphorylation | Uniprot | |
S453 | Phosphorylation | Uniprot | |
S459 | Phosphorylation | Uniprot | |
S461 | Phosphorylation | Uniprot |
Research Backgrounds
Transcription activator which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes. Controls cardiac morphogenesis and myogenesis, and is also involved in vascular development. Enhances transcriptional activation mediated by SOX18. Plays an essential role in hippocampal-dependent learning and memory by suppressing the number of excitatory synapses and thus regulating basal and evoked synaptic transmission. Crucial for normal neuronal development, distribution, and electrical activity in the neocortex. Necessary for proper development of megakaryocytes and platelets and for bone marrow B-lymphopoiesis. Required for B-cell survival and proliferation in response to BCR stimulation, efficient IgG1 antibody responses to T-cell-dependent antigens and for normal induction of germinal center B-cells. May also be involved in neurogenesis and in the development of cortical architecture (By similarity). Isoforms that lack the repressor domain are more active than isoform 1.
Phosphorylation on Ser-59 enhances DNA binding activity (By similarity). Phosphorylation on Ser-396 is required for Lys-391 sumoylation and inhibits transcriptional activity.
Acetylated by p300 on several sites in diffentiating myocytes. Acetylation on Lys-4 increases DNA binding and transactivation (By similarity).
Sumoylated on Lys-391 with SUMO2 but not by SUMO1 represses transcriptional activity.
Proteolytically cleaved in cerebellar granule neurons, probably by caspase 7, following neurotoxicity. Preferentially cleaves the CDK5-mediated hyperphosphorylated form which leads to neuron apoptosis and transcriptional inactivation.
Nucleus. Cytoplasm>Sarcoplasm.
Expressed in brain and skeletal muscle.
Forms a complex with class II HDACs in undifferentiating cells. On myogenic differentiation, HDACs are released into the cytoplasm allowing MEF2s to interact with other proteins for activation. Interacts with EP300 in differentiating cells; the interaction acetylates MEF2C leading to increased DNA binding and activation (By similarity). Interacts with HDAC7 and CARM1 (By similarity). Interacts with HDAC4 and HDAC9; the interaction with HDACs represses transcriptional activity. Interacts with LPIN1. Interacts with MYOCD. Interacts with AKAP13 (By similarity). Interacts with FOXK1; the interaction inhibits MEF2C transactivation activity (By similarity). Interacts (via N-terminus) with HABP4; this interaction decreases DNA-binding activity of MEF2C in myocardial cells in response to mechanical stress. Interacts with JPH2; interaction specifically takes place with the Junctophilin-2 N-terminal fragment cleavage product of JPH2 (By similarity). Interacts (via MADS box) with SOX18 (By similarity).
The beta domain, missing in a number of isoforms, is required for enhancement of transcriptional activity.
Belongs to the MEF2 family.
Research Fields
· Environmental Information Processing > Signal transduction > MAPK signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > cGMP-PKG signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Apelin signaling pathway. (View pathway)
· Human Diseases > Cancers: Overview > Transcriptional misregulation in cancer.
· Organismal Systems > Endocrine system > Oxytocin signaling pathway.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.